Results 221 to 230 of about 70,282 (281)

Novel Combined Approach for Vision‐Preserving Iridociliary Tumour Excision in a Small‐Breed Dog: Contralateral Iris Excision With En‐Bloc Scleral Resection

Veterinary Medicine and Science, Volume 12, Issue 2, March 2026.
• A 2.8 mm corneal paracentesis positioned opposite to the tumour location enabled fine iris scissors insertion for precise excision of tumour‐bearing iris tissue under miotic guidance with pilocarpine 2%. • A fornix‐based conjunctival peritomy 5 mm from the limbus and stepped scleral flap approach allowed circumferential deep scleral incision with 2–3 
Jae‐Ik Kang, Jeong‐Eun Yeom, Kyung‐Mee Park   +2 more
wiley   +1 more source

Optical coherence tomography-derived texture-based radiomics features identify eyes with intraocular inflammation in the HAWK clinical trial. [PDF]

Heliyon
Sil Kar S, Cetin H, Srivastava SK, Madabhushi A, Ehlers JP.   +4 more
europepmc   +1 more source

Low‐Molecular‐Weight Heparin for Adult ICU Patients Who Require Thromboprophylaxis: Protocol for the INCEPT‐Thromboprophylaxis Platform Trial Domain

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 3, March 2026.
ABSTRACT Background Low‐molecular‐weight heparin (LMWH) is recommended for thromboprophylaxis in adult intensive care unit (ICU) patients. Despite its widespread use, there is insufficient evidence on the optimal dose, and there appears to be practice variation.
Ruben Eck, Anders Granholm, Aske Tøgern, Aksel Karl Georg Jensen, Sandra Jonmarker, Fredrik Sjövall, Karina Meijer, Maria Cronhjort, Morten Hylander Møller, Anders Perner, Frederik Keus   +10 more
wiley   +1 more source

Visual outcomes of intraocular inflammation after brolucizumab injection in Japanese patients with neovascular age-related macular degeneration. [PDF]

PLoS One
Hirono K, Maruyama-Inoue M, Yanagi Y, Kadonosono K.   +3 more
europepmc   +1 more source

Factors Associated With Intraocular Inflammation in Neovascular Age-Related Macular Degeneration Patients Treated With Brolucizumab. [PDF]

Invest Ophthalmol Vis Sci
Hashimoto Y, Inoda S, Takahashi H, Takahashi R, Yoshida H, Fujino Y, Sakamoto S, Kawashima H, Yanagi Y.   +8 more
europepmc   +1 more source

A two‐step formula constant optimization strategy for minimal standard deviation and zero mean prediction error in IOL power calculation

Acta Ophthalmologica, Volume 104, Issue 2, Page 181-192, March 2026.
Abstract Purpose To investigate the precision and accuracy performance of a two‐step approach for optimizing lens formula constants (FC) with a refractive offset correction (RO) as a second tuning parameter. Methods Using IOLMaster 700 biometric data from 4 datasets (886/613/821/467 eyes treated with the Hoya Vivinex/Johnson&Johnson ZCB00/Alcon SA60AT ...
Achim Langenbucher, Nóra Szentmáry, Jascha Wendelstein, Alan Cayless, Peter Hoffmann, Damien Gatinel   +5 more
wiley   +1 more source

Interventions for submacular haemorrhage: A systematic review and network meta‐analysis of controversies—On behalf of the Spanish Vitreo‐Retinal Society (SERV)

Acta Ophthalmologica, Volume 104, Issue 2, Page 139-163, March 2026.
Abstract Purpose This systematic review aims to evaluate and synthesize the existing literature on the interventions used for submacular haemorrhage (SMH), highlighting the controversies and differences in clinical practice. Method A systematic review was conducted following the PRISMA guidelines.
Salvador Pastor‐Idoate, Pablo Redruello‐Guerrero, Laura de Juan Hernández, Gregorio Benites‐Narcizo, Mario Rivera‐Izquierdo, José García‐Arumí, José Carlos Pastor Jimeno   +6 more
wiley   +1 more source

Decoding the space integrome: Personalized countermeasures for a mission to Mars

Experimental Physiology, EarlyView.
Damian M. Bailey
wiley   +1 more source

Visual Morbidity and Outcomes of Scleritis Associated with Intraocular Inflammation Compared to Isolated Scleritis. [PDF]

Ocul Immunol Inflamm
Liao A, Fajoles-Vasseneix C, Rali A, Ward L, Fernandes A, Patel PS, O'Keefe G, Shantha JG, Yeh S.   +8 more
europepmc   +1 more source

Single oral administration of dronabinol increases ocular blood flow in patients with glaucoma

Acta Ophthalmologica, Volume 104, Issue 2, Page 225-232, March 2026.
Abstract Purpose Glaucoma is a leading cause of irreversible blindness globally, primarily driven by elevated intraocular pressure (IOP). Still, some patients progress despite significant IOP lowering, potentially due to impaired ocular blood flow. This study aimed to evaluate the effects of dronabinol, a synthetic tetrahydrocannabinol derivative, on ...
Theresa Lindner, Viktoria Pai, Patrick Janku, Nikolaus Hommer, Anton Hommer, Marihan Abensperg‐Traun, Liudmyla Petric, Leopold Schmetterer, Gerhard Garhöfer, Doreen Schmidl   +9 more
wiley   +1 more source